[go: up one dir, main page]

WO2000069548A1 - Membrane recuite au plasma pour separation des proteines - Google Patents

Membrane recuite au plasma pour separation des proteines Download PDF

Info

Publication number
WO2000069548A1
WO2000069548A1 PCT/US2000/013550 US0013550W WO0069548A1 WO 2000069548 A1 WO2000069548 A1 WO 2000069548A1 US 0013550 W US0013550 W US 0013550W WO 0069548 A1 WO0069548 A1 WO 0069548A1
Authority
WO
WIPO (PCT)
Prior art keywords
plasma
porous membrane
protein
gas
annealed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/013550
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota Twin Cities
University of Minnesota System
Original Assignee
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota Twin Cities, University of Minnesota System filed Critical University of Minnesota Twin Cities
Priority to AU48550/00A priority Critical patent/AU4855000A/en
Publication of WO2000069548A1 publication Critical patent/WO2000069548A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0081—After-treatment of organic or inorganic membranes
    • B01D67/009—After-treatment of organic or inorganic membranes with wave-energy, particle-radiation or plasma
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1425—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of whey, e.g. treatment of the UF permeate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/12—Composite membranes; Ultra-thin membranes
    • B01D69/125—In situ manufacturing by polymerisation, polycondensation, cross-linking or chemical reaction
    • B01D69/127—In situ manufacturing by polymerisation, polycondensation, cross-linking or chemical reaction using electrical discharge or plasma-polymerisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis

Definitions

  • This invention relates to porous membranes. More specifically, this invention relates to use of plasma-annealed porous membranes in separation and concentration of proteinaceous solutions and suspensions.
  • Porous materials have been increasingly applied to processing of solutions containing biological matter. These processes may involve filtration, clarification, fractionation, pervaporation, reverse osmosis, dialysis, affinity separation, blood oxygenation, or similarly related procedures.
  • a common occurrence in such processes is loss of process efficiency due to fouling of material surfaces by biological matter, and most particularly by proteinaceous matter. Such fouling robs these processes of their efficiency and cost effectiveness, entailing process downtime for cleaning and early replacement of irretrievably fouled portions of porous material components.
  • Proteinaceous biomolecules are highly complex, containing both hydrophilic and hydrophobic regions. These biomolecules are highly conformable and adaptable toward adsorption to surfaces having hydrophobic moieties thereat. They are inherently surface-active and readily bind to material surfaces at the surface-liquid interface. The problem of uncontrolled adsorption of proteinaceous matter extends through a myriad of processes and applications involving contact or processing of proteinaceous solutions and suspensions.
  • Ultrafiltration of whey through microporous polysulfone membranes provides a particularly prominent example of this problem.
  • Ultrafiltration membranes typically show extremely high throughputs of water when tested on pure water as a process feedstream.
  • Contact with a whey as a process feedstream almost always results in a prompt and drastic decline in flux through the same membrane.
  • Adsorption of proteinaceous matter, particularly beta-lactoglobulin and alpha-lactalbumin has been identified as a primary contributing cause for such drastic flux declines.
  • hydrophobic materials adsorb protein from aqueous solutions or suspensions. It is also generally known in the art that treatments to increase the hydrophilicity of materials often decrease protein adsorption. As a result, various treatments and approaches have been applied to making porous materials that have hydrophilic surfaces. Included in such approaches are methods employing application of hydrophilic polymer coatings, graft polymerizing hydrophilic monomers onto hydrophobic surfaces, treating hydrophobic surfaces with peroxides to alter surface chemistries, modifying with gas plasmas to alter surface chemistries or deposit hydrophilic plasma polymers, and blending or alloying hydrophilic polymers with hydrophobic polymers in the original preparation of the porous materials. Improvements in resistance to fouling by proteinaceous substances have been achieved in some measure by each of these approaches.
  • a hydrogel consisting of as high as 90% water content may still exhibit a hydrophobic surface by reason of orientation of hydrophobic moieties (as evidenced by contact angle measurements), and may show significant adsorption characteristics toward proteinaceous compounds in a solution or suspension in contact with the hydrogel.
  • a very tightly crosslinked polymeric structure having hydrophilic groups on its outer surface showed stable hydrophilicity. This was demonstrated by means of a plasma-polymerized poly(methane) layer treated with oxygen to develop surface hydroxyl groups. Such a coating remained hydrophilic over a 200 day period.
  • this approach has been utilized as an adjunct post-treatment in the manufacture of soft, wearable contact lenses, wherein the ocular contact surface has been treated with a methane-air mixture to provide improved hydrophilicity.
  • an optimum solution to the problem of biofouling of porous materials by proteinaceous matter must also take into consideration the softness and compressibility of porous polymeric materials, particularly as it relates to discriminating layers present in porous articles intended for contact and processing of biological solutions and suspensions.
  • membranes which have a highly beneficial combination of surface hardening and hydrophilicity by means of a treatment with a gas plasma process hereinafter referred to as "plasma annealing, " results in less adsorption of proteinaceous matter to exposed separation surfaces, greater throughput of permeate in filtrative and concentrative applications, and greater recovery of costly proteinaceous biologicals such as bioengineered proteins, enzymes, hormones and clotting factors.
  • porous membranes are plasma- annealed by treatment with a low temperature gas plasma generated by glow discharge through a gas containing a hydrocarbon such as an acetylene or a saturated alkane, then applied to separation or concentration of proteinaceous substances.
  • a low temperature gas plasma generated by glow discharge through a gas containing a hydrocarbon such as an acetylene or a saturated alkane
  • porous membranes are plasma-annealed by treatment with a low temperature gas plasma generated by glow discharge through a gaseous blend containing a saturated alkane blended with air and/or a hydrophilic unsaturated monomer, then applied to separation or concentration of proteinaceous substances.
  • a low temperature gas plasma generated by glow discharge through a gaseous blend containing a saturated alkane blended with air and/or a hydrophilic unsaturated monomer
  • greatly improved throughput of permeate is achieved due to decreased membrane softness and flow hysteresis, along with a greatly improved reduction in the surface adsorption characteristics of the membranes toward the proteinaceous substances.
  • Particularly preferred for utilization in protein concentrations and separations are plasma-annealed polysulfone membranes, wherein the plasma annealing was conducted in the presence of methane blended with air, oxygen and/or acrylic acid.
  • Such membranes exhibit greatly improved fluxes in filtration operations due to their retention of surface porosity, as well as improved surface hardness and
  • the improved processes which are the subject of this invention, are useful in the fractionation and concentration of various proteins in fluids, including blood, biological sera, milk, and whey, as well as concentration of soy protein isolates, enzymes, bioengineered proteinaceous hormones, and such like. Concentration or fractionation of a variety of biomaterials, in solution or suspension with proteins, may similarly be practiced within this invention. Similarly, improved processes in accord with this invention are useful in the separation of nonproteinaceous substances from protein-containing fluids and suspensions. Brief Description of Drawings
  • FIG. 1 is a graph of bore flow through polysulfone hollow fibers as a function of externally applied pressure.
  • FIG. 2 is a graph of permeate flow through polysulfone hollow fibers as a function of internally applied filtration pressure. Best Mode for Carrying Out the Invention
  • utilization of plasma- annealed membranes is made in applications involving separation and/or concentration of proteinaceous substances, and in separation or concentration of biomaterials such as hormones or saccharides or nucleic acid compounds in solutions or suspensions containing proteinaceous substances, wherein porous membranes having greatly improved fluxes and flux stability along with reduced affinity for adsorption of proteinaceous substances are prepared by exposing these membranes to a glow discharge gas plasma wherein exposed surfaces are simultaneously plasma-annealed and modified by deposition of a plasma polymerizate formed in a gas or gas mixture containing at least one alkane or acetylene, preferably with a hydrophilicity-generating co-monomer.
  • a gas or a blend of gases is fed into an evacuated chamber, the gas or blend of gases is excited to a plasma state by a glow discharge maintained by application of energy in the form of an audiofrequency, a microwave frequency or a radiofrequency field, and a suitable substrate is exposed to the glow discharge gas plasma, whereby exposed surfaces of the substrate are modified by deposition of a plasma polymerizate.
  • Apparatus suitable for conducting glow discharge treatments are known to one of ordinary skill in the art. Examples of such apparatus have been previously disclosed in a number of patents including for example U.S. 3,068,510, U.S. 4,147,745, U.S. 5,472,509, and U.S. 5,843,789, all of which are herein incorporated by reference.
  • Such apparatus includes equipment suitable for continuous treatment of large batches of porous material such as rolls of sheeting, spools of fiber, belts of mounted articles, or alternate arrays of articles to be treated.
  • Porous materials to be treated in accordance with this invention are generally to be chosen and fashioned from organopolymeric plastics. Porosity may vary from as little as 10% to as high as 90% , defined in terms of the density of the porous materials relative to the density of nonporous resins from which the materials are fashioned. Preferably, porosity of the porous materials to be treated in accordance with this invention will vary in the range of 30% to 85%.
  • the pores which account for the porosity of the porous materials may be open and interconnected or may be closed. For filtrative applications, such pores are preferably open and interconnected.
  • Average pore size range for these pores will range from about 10 angstroms to about 2 microns, preferably in the range of from about 20 angstroms to about 0.7 microns.
  • the porous materials may be in the form of sheets, film, fibers, tubes, hollow fibers, porous coatings, or otherwise shaped articles.
  • the matrix polymers of porous materials useful in this invention are chosen from the field of engineering resins, including aliphatic polyamides (nylons), aromatic polyamides (“aramids”), polysulfones, polycarbonates, polypropylenes, polyimides, polyetherimides, polyphenyleneoxides, polyesters, polyacrylonitriles, copolymers and terpolymers based on one or more of these polymers, and polymeric blends containing one or more of these polymers.
  • These source polymers are routinely available in the form of pelletized engineering resins, and many of these polymers are particularly noted for their rigidity and strength.
  • porous materials such as ultrafiltration and microfiltration membranes
  • processing of these polymers into porous materials commonly results in porous articles whose surfaces are soft and easily marred by almost any kind of rubbing or abrasive contact.
  • This softness appears to account for at least a portion of hysteresis effects commonly observed in porous membrane materials in pressurized filtrative and concentrative applications and heretofore generally attributed solely to biofouling.
  • porous materials are often highly compressible, as well, depending on degree of porosity. In addition to this softness, these materials may at times exhibit a tendency to absorb organic components from biological solutions directly into their polymeric matrices, further exacerbating the problem of softness and pressure hysteresis.
  • these porous materials are plasma-annealed in a gas plasma treatment apparatus generally by placing the materials in such an apparatus, evacuating the apparatus to a suitable state of vacuum, admitting a preferred mixture of gases, and initiating a glow discharge plasma through the gas mixture in a region defined be glow discharge electrodes.
  • the glow discharge may be either generated in instant contact with the porous materials or alternatively in conjunction with subsequent passage of the porous materials through the glow discharge region.
  • the gas mixture is to contain an acetylene or a saturated alkane, preferably a saturated alkane, optionally with a second gas consisting of either a hydrophilic unsaturated monomer or a source of oxygen (such as air).
  • gases may be present, including generally inert gases such as argon or nitrogen.
  • inertness herein is meant that such gases have very low tendency, or essentially no tendency, to be chemically incorporated into either the chemical structure of the porous material surfaces or into the chemical structure of any plasma polymerizate deposited onto the porous material surfaces.
  • pure oxygen may be added into the vacuum apparatus, or admitted as air, or may optionally be provided in the form of an oxygen precursor instead of oxygen, insofar as such precursor (hydrogen peroxide, water, ozone, etc.) generates within the glow discharge region a significant population of the same species as would be generated by a glow discharge through a mixture containing gaseous oxygen.
  • Air is a particularly preferred source of oxygen for the plasma annealing process, due to its easy availability and essentially zero cost. Air is generally defined herein to include about 78% nitrogen gas and about 21 % oxygen gas.
  • the alkane is preferably a low molecular weight, saturated hydrocarbon chosen from the group represented by methane, ethane, and propane, all of which are permanent gases at normal ambient atmospheric conditions. Particularly preferred is methane as the alkane. Methane is rather difficultly polymerized by gas plasma techniques, and a methane plasma reluctantly deposits a polymerizate at a notably slow deposition rate. Two advantages are derived thereby. First, greater exposure time may be used for plasma annealing of a porous material in a methane-based plasma, since deposition of the plasma polymerizate deposit is slow and controlled. Second, surface pores are not likely to be filled or blocked by a thick coating of plasma polymerizate, in that the deposition rate is so slow.
  • a plasma polymerizate of methane will contain residual reactive sites, typically radical or radical-ion sites. These sites will react with air and/or contaminants subsequent to the plasma annealing process. Such sites are preferably eliminated in the current invention by simultaneous exposure to oxygen within the glow discharge zone. Oxygen reacts with these radical sites immediately upon their formation, resulting in two immediate benefits: greatly reduced residual activity, and controlled improvement of hydrophilicity.
  • the hydrocarbon gas may be used within the glow discharge apparatus at system pressures in the range from about 2.6 to about 130 Pa (20 - 1000 mtorr), preferably in the range from about 4 to about 26 Pa (30 - 200 mtorr) .
  • Oxygen gas may be used within the same apparatus at pressures in generally the same range as the hydrocarbon gas, generally when the hydrocarbon gas is a saturated alkane such as methane.
  • the hydrophilic unsaturated monomer, preferably acrylic acid, may also be used within the same apparatus at pressures in generally the same range as the hydrocarbon gas.
  • Blends of the hydrocarbon with the unsaturated organic monomer may also be used under similar conditions, a preferred example of such a blend being a mixture of methane and acrylic acid,
  • the overall system pressure in the apparatus during the plasma annealing process may vary in the range of from about 6.5 to about 260 Pa (50 - 2000 mtorr).
  • nonpolymerizable gases are blended with the monomer vapor, continuous removal of excess gases is accomplished by a simultaneous pumping through the vacuum port to a vacuum source. Since some nonpolymerizable gases are often evolved from glow discharge gas plasmas, it is advantageous to control gas plasma pressure at least in part through simultaneous vacuum pumping during plasma polymerizate deposition on a substrate during the plasma annealing process of this invention.
  • the deposition rate for a plasma polymerizate onto the porous materials from these gas blends may vary from a low of generally about one angstrom thickness per minute of exposure time to a high of generally about 100 angstroms thickness per minute of exposure time.
  • High deposition rates are not necessarily advantageous to the plasma-annealing process, in that undesirably thick coatings may be deposited during the time necessary to achieve the annealing effect.
  • Deposition rates can be altered by control of monomer pressure and by intensity of the glow discharge. The latter may be readily accomplished by one skilled in the art through design of the apparatus reaction chamber, placement of the electrodes, and power applied through the electrodes.
  • plasma annealing it is preferred to operate at low discharge power, in the range of from about 75 watts to about 150 watts discharge power.
  • a nominally 100 watt discharge power has been used with great success in plasma annealing of porous substrates.
  • the time of exposure needed to achieve plasma annealing of the soft polymer surface in porous materials is in the range of about one second to about two minutes, preferably from about one second to about 20 seconds.
  • the glow discharge through the gas or blend of gases in the vacuum chamber may be initiated by means of an audiofrequency, a microwave frequency or a radiofrequency field transmitted to or through a zone in the vacuum chamber.
  • a radiofrequency (RF) discharge transmitted through a spatial zone in the vacuum chamber by an electrode connected to an RF signal generator.
  • RF radiofrequency
  • Electrodes are preferably located exteriorly to the vacuum chamber, but may be positioned within the vacuum chamber. A rather broad range of RF signal frequencies starting as low as 50 kHz may be used in causing and maintaining a glow discharge through the monomer vapor.
  • the 50 kHz frequency was used with good effect in the experimental examples given at the end of this disclosure.
  • an assigned radiofrequency of 13.56 MHz may be more preferable to use to avoid potential radio interference problems.
  • the following examples are given: first, to illustrate the plasma annealing process as it is preferably carried out, including representative gas blends, operating conditions, and deposition rates for plasma polymerizates onto the surfaces being simultaneously annealed; second, to illustrate the utility and use of resulting plasma- annealed membranes in the concentration of proteinaceous substances such as cheese whey protein, also therewith demonstrating the hardening (i.e. , annealing) effects of the plasma-annealing process and the reduced adsorptive characteristics and biofouling potential of the processed materials toward proteinaceous substances.
  • Deposition rates of plasma polymerizates onto surfaces were determined for methane and acrylic acid under plasma annealing conditions of 100 watts discharge power and varying monomer flow rates and system pressures as shown in Table 1.
  • Deposition rates in the typical plasma processing conditions of this invention were about 0.6 to about 1.4 angstroms per second in the case of methane and about 24 to about 34 angstroms per second in the case of acrylic acid. In that very little plasma polymer deposition (i.e. , about 20 angstroms) is preferred in the plasma annealing process, these deposition rates provided guidance for optimum exposure time of porous materials to gas plasmas utilizing methane or alternatively acrylic acid.
  • Polysulfone sheet membrane was obtained from Millipore Corporation (U.S.A.) having a product name designation of Minitan-S, and characterized as having a nominal molecular weight cut-off of 10,000 daltons. Portions of this sheet membrane weremolecular weight cut-off of 10,000 daltons. Portions of this sheet membrane were treated by plasma annealing with plasma polymerizate deposition under three sets of conditions as set forth in Table 2, at a discharge power of 100 watts. Blends of methane/air and methane/acetic acid were used in the plasma annealing process. Coating thicknesses were estimated from plasma exposure time at the process conditions, and resulting products were characterized for weak ion exchange capacity and water contact angle. A change in the hydrophilicity of the TABLE 1
  • Polysulfone sheet membrane was obtained from Osmonics Corporation (U.S.A.) consisting of an industrial ultrafiltration membrane characterized as having a nominal molecular weight cut-off of 10,000 daltons. Portions of this sheet membrane were treated by plasma annealing with plasma polymerizate deposition under three sets of conditions as set forth in Table 3, at a discharge power of 100 watts. Blends of methane/air and methane/acetic acid were used in the plasma annealing process. Coating thicknesses were estimated from plasma exposure time at the process conditions, and resulting products were characterized for weak ion exchange capacity and water contact angle. A change in the hydrophilicity of the treated surfaces was noted by decreased water contact angles - 40 to 50 degrees - compared with untreated membrane which showed a water contact angle of 60 degrees under identical measurement conditions.
  • Fresenius AG (Germany). It had a product name designation of PSP 600, and was characterized as having a nominal molecular weight cut-off of 30,000 daltons.
  • This fiber was treated in a gas plasma apparatus by exposing the outer surface of the hollow fiber to a glow discharge generated in methane gas. The fiber was passed from a source spool to take-upthrough the gas plasma for a total plasma annealing exposure time of 18 seconds.
  • the plasma- treated fiber was assembled into a hollow fiber module by conventional methods, and contained 75 fibers of 15 cm length. The fiber in the module was tested for the effect of hydraulic pressure on water permeation rate. The effect of plasma annealing was shown by means of the following type of test.
  • Polysulfone hollow fibers described in Example 10 were treated with glow discharge gas plasmas at a discharge power of 50 watts under the conditions in Table 4, using methane as an annealing gas and air (oxygen) or acrylic acid as hydrophilic plasma gases. These examples were evaluated for protein adsorption characteristics by exposing them to a streptavidin assay procedure commonly used in genomic analyses. Streptavidin- AP in tris-buffered saline solution, 0.53 nmol/liter, was applied to the modified fibers and to an untreated control to determine the degree of protein adsorption. The presence and amount of streptavidin- AP adsorbed onto the fibers was measured by chemiluminescence development techniques, counting relative light units (RLU) via a luminometer.
  • RLU relative light units
  • Untreated control fiber was measured for streptavidin- AP adsorption by the same technique. Chemiluminescence readings were taken as a measure of adsorbed streptavidin- AP, and readings were compared. Examples 11 and 12 showed only 36% and 23% as much streptavidin adsorption as the untreated control fiber based on luminometer chemiluminescence readings. Example 13 showed only 6% of the level of the protein adsorption observed for untreated fiber in the streptavidin challenge, showing remarkable resistance to protein adsorption.
  • the plasma-annealed membrane made according to the procedure of Example 9 was assembled into a spirally wound membrane filtration element by a standard approach well known in the reverse osmosis and ultrafiltration membrane industry.
  • the spiral element had an approximate filtration area of 0.475 square meters.
  • a spiral element was also assembled from nontreated but otherwise identical membrane for comparative purposes.
  • the plasma-annealed and nontreated membrane elements were mounted in an ultrafiltration system and contacted with pH 6.3-6.4 cheese whey in a nonconcentrative mode (permeate returned to feed reservoir containing 400 ml cheese whey) at 50 °C, 20 psig hydraulic pressure for 120 minutes, with monitoring of permeate flow rates.
  • Example 14 In the same manner as described in Example 14, a plasma-annealed membrane made according to the procedure of Example 7 was assembled into a spirally wound membrane filtration element and sequentially cycled through contact with water, then cheese whey, for three consecutive cycles. Permeate fluxes for these cycles are shown in Table 6 for the plasma-annealed membrane element, and the data ratios to the untreated element data (from Table 5) are listed. The data in Table 6 again demonstrate both that the plasma-annealed membrane routinely displayed higher fluxes toward cheese whey compared to the untreated membrane, and also that the plasma- annealed membrane showed a far more stable flux curve toward water (less hysteresis) compared to the untreated membrane.
  • EXAMPLE 16 A plasma-annealed membrane made according to the procedure of Example 6, except that system pressure was 400 mtorr and discharge power was 50 watts. This plasma-annealed membrane was assembled into a spirally wound membrane filtration element and was sequentially cycled through contact with water and cheese whey in the same manner as in Example 15. Permeate fluxes for these cycles are shown in Table 7 along with data ratios as calculated in the manner of the previous table.
  • the three spiral elements used in examples 14-16 were used to concentrate cheese whey. Each was operated in a concentrative mode, along with a control element containing untreated polysulfone ultrafiltration membrane. Concentrations were conducted for a three hour (180 min) period in each case. Permeate was collected and permeate flux was monitored periodically throughout the three hour runs. After each run, the elements were washed and rinsed. Then concentration runs were repeated with a fresh batch of cheese whey. Each element experienced three consecutive concentration cycles. Table 8 contains flux data for each element for each TABLE 6
  • Plasma-annealed membrane elements showed from 55% to 126% more flux than the untreated membrane element during these tests. These favorable ratios were achieved even in light of the fact that the plasma-annealed membrane elements were dealing with a higher level of protein content in the latter portions of the concentration cycles than the untreated control due to their higher permeate fluxes. This is revealed by means of the data in Table 9, which show the concentration factors achieved by the plasma-annealed membrane elements.
  • the plasma-annealed membrane elements achieved at least a 4-fold concentration factor to as high as a 14-fold concentration factor in these cycles, compared to only a 1.8-fold concentration factor by the untreated membrane element.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plasma & Fusion (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

La présente invention concerne des membranes polymères poreuses améliorées, recuites par un processus de recuit au plasma, qui sont utilisées dans les séparations et les applications de concentration appliquées à des solutions ou des suspensions contenant des substances protéiques. Les membranes poreuses de l'invention, qui ont été exposées à une décharge luminescente à travers un mélange gazeux contenant un alcane tel que le méthane combiné à de l'oxygène, de l'air ou un monomère organique insaturé hydrophile, présentent une densité de flux grandement améliorée envers les fluides contenant des protéines, ce qui entraîne une réduction de l'encrassement de la membrane par les protéines ou de la perte de protéines due à l'adsorption sur les surfaces de la membrane. Les membranes recuites au plasma de l'invention sont utilisées dans les fractionnements et les séparations appliquées à des fluides contenant des protéines.
PCT/US2000/013550 1999-05-18 2000-05-17 Membrane recuite au plasma pour separation des proteines Ceased WO2000069548A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU48550/00A AU4855000A (en) 1999-05-18 2000-05-17 Plasma-annealed membrane for protein separation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31427099A 1999-05-18 1999-05-18
US09/314,270 1999-05-18

Publications (1)

Publication Number Publication Date
WO2000069548A1 true WO2000069548A1 (fr) 2000-11-23

Family

ID=23219283

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/013550 Ceased WO2000069548A1 (fr) 1999-05-18 2000-05-17 Membrane recuite au plasma pour separation des proteines

Country Status (2)

Country Link
AU (1) AU4855000A (fr)
WO (1) WO2000069548A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6967105B2 (en) * 2000-12-02 2005-11-22 Queststar Medical, Inc. Surface-modified wick for diagnostic test strip
US9055752B2 (en) 2008-11-06 2015-06-16 Intercontinental Great Brands Llc Shelf-stable concentrated dairy liquids and methods of forming thereof
KR20180008427A (ko) * 2015-04-30 2018-01-24 에스아이오2 메디컬 프로덕츠, 인크. 열가소성 물품으로의 희석 생체분자 부착의 감소를 가져오는 비중합성 화합물을 이용한 플라즈마 처리
US11490629B2 (en) 2010-09-08 2022-11-08 Koninklijke Douwe Egberts B.V. High solids concentrated dairy liquids
US12195603B2 (en) 2014-12-17 2025-01-14 Sio2 Medical Products, Llc Polymeric surface having reduced biomolecule adhesion to thermoplastic articles and methods of plasma treatment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60158231A (ja) * 1984-01-30 1985-08-19 Agency Of Ind Science & Technol 重合体の表面処理方法
US5468844A (en) * 1994-01-07 1995-11-21 Protose Technologies Inc. Process for the membrane-filtering of protein solutions
WO1996036877A1 (fr) * 1995-05-16 1996-11-21 Neomecs Incorporated Matieres poreuses pour analyses genomiques

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60158231A (ja) * 1984-01-30 1985-08-19 Agency Of Ind Science & Technol 重合体の表面処理方法
US5468844A (en) * 1994-01-07 1995-11-21 Protose Technologies Inc. Process for the membrane-filtering of protein solutions
WO1996036877A1 (fr) * 1995-05-16 1996-11-21 Neomecs Incorporated Matieres poreuses pour analyses genomiques
US5843789A (en) * 1995-05-16 1998-12-01 Neomecs Incorporated Method of analysis of genomic biopolymer and porous materials for genomic analyses

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 198612, Derwent World Patents Index; AN 1986-077671, XP002146095 *
JOURNAL OF APPLIED POLYMER SCIENCE, vol. 47, no. 12, 20 March 1993 (1993-03-20), new york,us, pages 2125 - 2133, XP000445562 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6967105B2 (en) * 2000-12-02 2005-11-22 Queststar Medical, Inc. Surface-modified wick for diagnostic test strip
US9055752B2 (en) 2008-11-06 2015-06-16 Intercontinental Great Brands Llc Shelf-stable concentrated dairy liquids and methods of forming thereof
US11490629B2 (en) 2010-09-08 2022-11-08 Koninklijke Douwe Egberts B.V. High solids concentrated dairy liquids
US12195603B2 (en) 2014-12-17 2025-01-14 Sio2 Medical Products, Llc Polymeric surface having reduced biomolecule adhesion to thermoplastic articles and methods of plasma treatment
KR20180008427A (ko) * 2015-04-30 2018-01-24 에스아이오2 메디컬 프로덕츠, 인크. 열가소성 물품으로의 희석 생체분자 부착의 감소를 가져오는 비중합성 화합물을 이용한 플라즈마 처리
KR102670650B1 (ko) * 2015-04-30 2024-05-31 에스아이오2 메디컬 프로덕츠, 인크. 열가소성 물품으로의 희석 생체분자 부착의 감소를 가져오는 비중합성 화합물을 이용한 플라즈마 처리

Also Published As

Publication number Publication date
AU4855000A (en) 2000-12-05

Similar Documents

Publication Publication Date Title
US6203850B1 (en) Plasma-annealed porous polymers
EP0880401B1 (fr) Procede de traitement de membranes polyamides pour accroitre le debit
Ma et al. Membrane fouling reduction by backpulsing and surface modification
Taniguchi et al. Low fouling synthetic membranes by UV-assisted graft polymerization: monomer selection to mitigate fouling by natural organic matter
Ulbricht et al. Surface modification of ultrafiltration membranes by low temperature plasma II. Graft polymerization onto polyacrylonitrile and polysulfone
CN1180876C (zh) 具有聚环氧烷改善聚酰胺表面的复合膜
US4765897A (en) Polyamide membranes useful for water softening
EP0275027B1 (fr) Membranes d'osmose inverse
EP1325062B1 (fr) Greffe assistee par ultraviolet de membranes de polyethersulfone
US20120031842A1 (en) Method for modifying composite membranes for liquid separations
CA2530805A1 (fr) Membranes comportant de l'ether polyvinylmethylique et hydrophilisation de membranes a l'aide d'ether polyvinylmethylique
US4265959A (en) Process for producing semipermeable membranes
JP6464866B2 (ja) 表面修飾基材、ポリマー被覆基材、およびそれらの製造方法
Belfer et al. Characterization of commercial RO and UF modified and fouled membranes by means of ATR/FTIR
Poźniak et al. Sulfonated polysulfone membranes with antifouling activity
WO2000069548A1 (fr) Membrane recuite au plasma pour separation des proteines
CN115253715A (zh) 一种具有多层结构的高脱盐复合反渗透膜及其制备方法
US5151183A (en) Reduction of membrane fouling by surface fluorination
US10561990B2 (en) Method for producing antifouling coatings made of thin-layer composite membranes for reverse osmosis and nanofiltration
Kravets et al. Modification of properties of polymer membranes by low-temperature plasma treatment
Meier‐Haack et al. Use of polyelectrolyte multilayer systems for membrane modification
CN114632429A (zh) 含复合脱盐层的复合纳滤膜及其制备方法
Ohansson et al. Fouling and protein adsorption effect of low-temperature plasma treatment of membrane surfaces
JP2005349268A (ja) 多孔性膜の拡散現象を利用した物質分離精製方法
JPS6331501A (ja) 複合半透性膜およびその製造方法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP